Alexion Pharmaceuticals, Inc.

$1.4B revenue • 1,001 employees • 801 Pennsylvania Avenue NW #830, Washington, DC, 20004, United States

Last Updated May 27, 2025

Company Overview

Company Name

Alexion Pharmaceuticals, Inc.

Address

801 Pennsylvania Avenue NW #830, Washington, DC, 20004, United States

Approx. Annual Revenue

$1400.0M

Employees

1,001

About Alexion Pharmaceuticals, Inc.

Alexion, AstraZeneca Rare Disease is a company headquartered in Washington, DC, United States, with approximately 1,001 employees. The company is dedicated to delivering life-changing therapies to people living with rare diseases, focusing on research, development, and innovation in areas such as bone metabolism, cardiology, endocrinology, and more.

Frequently Asked Questions about Alexion Pharmaceuticals, Inc.

Technologies Used

Social Profiles

Key Decision Makers

Chris Johnson Executive Director, Head of U.S. Sales
LinkedIn
Ron Gugliotti Director of Clinical Development
LinkedIn
Sahar Esteghamat, MSc, PhD Director-Clinical Development Scientist
LinkedIn
Ghaith Mitri Sr. Medical Director, Clinical Development, Rheumatology & Rare Diseases - Neurology & Ophthalmology
LinkedIn
Disha Patel Clinical Trial Manager - II
LinkedIn
Theodore Wing Senior Clinical Research Associate
LinkedIn
Sharitta Cuttino Senior Clinical Research Associate
LinkedIn
Thema Marie V. Sr. Clinical Research Associate
LinkedIn
Ashwan Errawalla Clinical Trial Manager
LinkedIn
Elizabeth Buckley Clinical Trial Manager
LinkedIn
Cesar Delcompare Clinical Trial Manager II
LinkedIn
Yikun Guo Clinical Trial Manager II
LinkedIn